Back
Travere Therapeutics Quote, Financials, Valuation and Earnings
Buy
51
TVTX
Travere Therapeutics
Last Price:
6.0700
Seasonality Move:
2.37%
7 Day Trial
ALL ACCESS PASS
$
7
Travere Therapeutics Price Quote
$6.0700
-0.6200 (-9.27%)
(Updated: May 17, 2024 at 6:55 PM ET)
Travere Therapeutics Key Stats
Buy
51
Travere Therapeutics (TVTX)
is a Buy
Day range:
$6.6000 - $7.0900
52-week range:
$5.1200 - $19.5424
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.79
P/B ratio:
6.88%
Volume:
929.9K
Avg. volume:
1.3M
1-year change:
-59.41%
Market cap:
$509.3M
Revenue:
$145.2M
EPS:
$-2.1
How Much Does Travere Therapeutics Make?
-
How Much Are Travere Therapeutics's Sales Annually?
TVTX Revenues are $145.2M -
How Much Profit Does Travere Therapeutics's Make A Year?
TVTX net income is -$111.4M
Is Travere Therapeutics Growing As A Company?
-
What Is Travere Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.34% -
What Is Travere Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Travere Therapeutics Stock Price Performance
-
Did Travere Therapeutics Stock Go Up Last Month?
Travere Therapeutics share price went up by 8.78% last month -
Did TVTX's Share Price Rise Over The Last Year?
TVTX share price fell by -59.41% over the past 1 year
What Is Travere Therapeutics 52-Week High & Low?
-
What Is Travere Therapeutics’s 52-Week High Share Price?
Travere Therapeutics has traded as high as $19.5424 over the past 52 weeks -
What Is Travere Therapeutics’s 52-Week Low Share Price?
Travere Therapeutics has traded as low as $5.1200 over the past 52 weeks
Travere Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Travere Therapeutics?
-
How Much Debt Does Travere Therapeutics Have?
Total long term debt quarterly is $377.7M -
How Much Cash Does Travere Therapeutics Have?
Cash and short term investments quarterly total is $441M -
What Is Travere Therapeutics’s Book Value Per Share?
Book value per share is 0.97
Is Travere Therapeutics Cash Flow Positive?
-
What Is TVTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$317.9M -
What Is Travere Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.2M -
What Is Travere Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $197.7M
Travere Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
TVTX return on invested capital is -29.36% -
What Is Travere Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -21.04% -
What Is TVTX Return On Equity?
ROE is a measure of profitability and is -93.65%
Travere Therapeutics Earnings Date & Stock Price
-
What Is Travere Therapeutics's Stock Price Today?
A single share of TVTX can be purchased today for 6.6900 -
What Is Travere Therapeutics’s Stock Symbol?
Travere Therapeutics trades on the nasdaq under the ticker symbol: TVTX -
When Is Travere Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Travere Therapeutics is scheduled on August 2, 2024 -
When Is TVTX's next ex-dividend date?
Travere Therapeutics's next ex-dividend date is May 18, 2024 -
How To Buy Travere Therapeutics Stock?
You can buy Travere Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Travere Therapeutics Competitors
-
Who Are Travere Therapeutics's Competitors?
Below is a list of companies who compete with Travere Therapeutics or are related in some way:
Travere Therapeutics Dividend Yield
Data Unavailable
Travere Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -90.61% |
| Revenue: | 33.95% | -5.14% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 0 |
| Price Target: | 14.8571 |
| Upside from Last Price: | 122.08% |